Ryann Grochowski Jones
- twitter: ryanngro
Our Hottest Stories
Ryann Grochowski Jones is a data reporter at ProPublica. Previously, she was a data reporter for Investigative Newsource/KPBS in San Diego, Calif. She received her master’s degree from the University of Missouri School of Journalism, where she was a data librarian for Investigative Reporters and Editors/National Institute for Computer-Assisted Reporting. Ryann started her career as a municipal beat reporter for her hometown newspaper in Wilkes-Barre, Pa.
July 1, 4:11 p.m.Pharmaceutical and medical device companies paid billions to doctors from late 2013 through 2014, new data shows. Search for your doctor in our interactive database.
July 1, 4:09 p.m.New data on payments from drug and device companies to doctors show that many doctors received payments on 100 or more days last year. Some received payments on more days than they didn't.
June 10, 10:51 a.m.Congress wouldn’t allow Medicare to pay for benzodiazepines such as Xanax and Ativan until 2013. Now, the medications are among the most prescribed in its drug program.
May 15, 9 a.m.How U.S. commanders spent $2 billion of petty cash in Afghanistan
Feb. 5, 12:57 p.m.A year after we launched it, here’s what our Data Store looks like.
Feb. 3, 3:48 p.m.The ridesharing service published a report last week with Mothers Against Drunk Driving connecting the rise of Uber to a drop in drunk driving accidents. Except the connection isn't so clear.
Jan. 22, NoonFlaws in information submitted to Open Payments, a government database of financial relationships in the medical field, complicated our analysis.
Jan. 7, 3 p.m.Our comprehensive analysis of drug company spending on doctors in the last five months of 2013 shows the most-promoted products typically were not cures, breakthroughs or top sellers.
Jan. 7, 3 p.m.Even with new federal data, it's not easy to track drug, device company spending on their products
Jan. 7, 3 p.m.Beginning in 2014, the federal government mandated that pharmaceutical and medical device manufacturers publicly report payments made to doctors and teaching hospitals. The first report covered the last five months of 2013. Use this tool to search for a company, drug or device.
Dec. 24, 2014, 2:14 p.m.We respond to arguments levied against our analysis of justified homicides by police officers.
Dec. 15, 2014, 1 p.m.Despite warnings about abuse, Medicare covered more prescriptions for potent controlled substances in 2012 than it did in 2011. The program's top prescribers often have faced disciplinary action or criminal charges related to their medical practices.
Dec. 4, 2014, 11:57 a.m.A ProPublica analysis found that many health insurance plans offered in the federal Affordable Care Act marketplace are changing their benefits heading into 2015. Consumers have until Dec. 15 to switch plans before they are automatically re-enrolled.
Oct. 10, 2014, 11:07 a.m.A ProPublica analysis of killings by police shows outsize risk for young black males.
Sep. 29, 2014, 9:20 a.m.Payments from pharmaceutical companies touch hundreds of thousands of doctors. The 17 companies we've tracked spent $1.4 billion in 2013 year alone. Here are our top five takeaways from following all that money.
Sep. 4, 2014, 10:33 a.m.The states have passed hard-nosed laws and taken an aggressive tack toward employers who misclassify independent contractors.
June 16, 2014, 11 a.m.The nonprofit Health Data Consortium held its fifth-annual Health Datapalooza last week in Washington, D.C. Here are some highlights.
May 15, 2014, 11:45 a.m.We found some doctors who billed for the most costly, most complex visits almost exclusively and charged top rates far more than their peers.
May 15, 2014, 11:45 a.m.Use this tool to find and compare providers.
May 15, 2014, 11:45 a.m.Medicare paid for more than 200 million office visits for established patients in 2012. Overall, health professionals classified only 4 percent as complex enough to command the most expensive rates. But 1,800 providers billed at the top level at least 90 percent of the time, ProPublica found.
Safeguard the public interest.
Support ProPublica’s award-winning investigative journalism.